Silicon Laboratories (SLAB) Financials

$125.38 +3.95 (+3.25%)

Closing price 05/27/2025 04:00 PM Eastern

Extended Trading

$125.37 -0.01 (-0.01%)

As of 05/27/2025 05:02 PM Eastern

Annual Income Statements for Silicon Laboratories

This table shows Silicon Laboratories' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/28/2024	12/30/2023	12/31/2022	1/1/2022	1/2/2021	12/28/2019	12/29/2018	12/30/2017	12/31/2016	1/2/2016
Net Income / (Loss) Attributable to Common Shareholders	-191	-35	91	2,117	13	19	84	47	61	30
Consolidated Net Income / (Loss)	-191	-35	91	2,117	13	19	84	47	61	30
Net Income / (Loss) Continuing Operations	-191	-35	91	-58	-115	-103	84	47	61	30
Total Pre-Tax Income	-155	-11	126	-58	-132	-96	72	77	64	30
Total Operating Income	-165	-24	119	-33	-107	-89	85	85	66	32
Total Gross Profit	312	461	643	425	295	280	521	454	422	381
Total Revenue	584	782	1,024	721	511	474	868	769	698	645
Operating Revenue	584	782	1,024	721	511	474	868	769	698	645
Total Cost of Revenue	272	322	382	295	216	194	347	315	276	264
Operating Cost of Revenue	272	322	382	295	216	194	347	315	276	264
Total Operating Expenses	478	485	523	458	402	369	436	369	355	349
Selling, General & Admin Expense	145	147	191	185	167	163	198	160	155	160
Research & Development Expense	332	338	332	273	235	206	238	209	200	188
Total Other Income / (Expense), net	11	14	7.19	-25	-25	-7.37	-13	-8.07	-1.78	-1.97
Interest Expense	1.31	5.55	6.72	31	34	20	20	14	2.59	2.83
Interest & Investment Income	12	19	14	5.70	9.03	13	6.65	6.06	0.81	0.86
Income Tax Expense	36	7.94	38	13	-15	6.98	-11	30	3.00	0.68
Other Gains / (Losses), net	0.00	-16	3.40	14	2.12	0.32	-	-	-	-
Basic Earnings per Share	($5.93)	($1.09)	$2.61	$49.44	$0.29	$0.44	$1.94	$1.11	$1.47	$0.70
Weighted Average Basic Shares Outstanding	32.19M	31.80M	35.09M	42.83M	43.78M	43.35M	43.16M	42.45M	41.71M	42.31M
Diluted Earnings per Share	($5.93)	($1.09)	$2.54	$47.78	$0.28	$0.43	$1.90	$1.09	$1.45	$0.69
Weighted Average Diluted Shares Outstanding	32.19M	31.80M	36.04M	44.32M	44.37M	44.29M	44.04M	43.33M	42.38M	42.95M
Weighted Average Basic & Diluted Shares Outstanding	32.46M	31.90M	31.90M	38.20M	43.93M	43.50M	557.30M	42.40M	41.80M	42.30M

This table shows Silicon Laboratories' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Net Income / (Loss) Attributable to Common Shareholders	-24	-29	-82	-57	-70	10	11	14	25	21
Consolidated Net Income / (Loss)	-24	-29	-82	-57	-70	10	11	14	25	21
Net Income / (Loss) Continuing Operations	-24	-29	-82	-57	-70	10	11	14	25	21
Total Pre-Tax Income	-26	-26	-45	-57	-70	14	23	23	27	33
Total Operating Income	-29	-30	-48	-59	-73	12	17	20	24	30
Total Gross Profit	90	90	77	55	44	119	144	154	157	166
Total Revenue	166	166	145	106	87	204	245	247	257	270
Operating Revenue	166	166	145	106	87	204	245	247	257	270
Total Cost of Revenue	76	76	69	51	43	85	101	93	100	104
Operating Cost of Revenue	76	76	69	51	43	85	101	93	100	104
Total Operating Expenses	119	120	125	114	117	107	127	134	133	135
Selling, General & Admin Expense	36	37	39	34	34	28	41	45	47	51
Research & Development Expense	82	83	86	81	83	79	86	89	87	85
Total Other Income / (Expense), net	2.72	3.21	2.53	2.22	2.67	1.58	6.18	3.18	2.45	3.15
Interest Expense	0.26	0.28	0.26	0.51	0.94	1.36	1.60	1.66	1.85	1.53
Interest & Investment Income	2.98	3.49	2.79	2.73	3.61	2.94	7.78	4.84	4.30	4.67
Income Tax Expense	-2.09	2.01	37	-0.39	-16	3.39	12	7.75	1.58	14
Basic Earnings per Share	($0.72)	($0.88)	($2.56)	($1.77)	($2.21)	$0.33	$0.35	$0.44	$0.77	$0.62
Weighted Average Basic Shares Outstanding	32.19M	32.31M	32.12M	31.91M	31.80M	31.80M	31.61M	31.96M	35.09M	34.08M
Diluted Earnings per Share	($0.72)	($0.88)	($2.56)	($1.77)	($2.15)	$0.32	$0.33	$0.41	$0.76	$0.60
Weighted Average Diluted Shares Outstanding	32.19M	32.31M	32.12M	31.91M	31.80M	32.08M	32.93M	33.75M	36.04M	34.78M
Weighted Average Basic & Diluted Shares Outstanding	32.46M	32.45M	32.29M	31.92M	31.90M	31.78M	31.86M	32.00M	31.90M	33.28M

This table details how cash moves in and out of Silicon Laboratories' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/28/2024	12/30/2023	12/31/2022	1/1/2022	1/2/2021	12/28/2019	12/29/2018	12/30/2017	12/31/2016	1/2/2016
Net Change in Cash & Equivalents	54	-272	-575	872	-24	30	-72	128	27	-28
Net Cash From Operating Activities	-14	-30	141	91	-8.84	22	174	190	129	105
Net Cash From Continuing Operating Activities	-14	-30	141	91	-8.84	22	174	190	129	105
Net Income / (Loss) Continuing Operations	-191	-35	91	-58	-115	-103	84	47	61	30
Consolidated Net Income / (Loss)	-191	-35	91	2,117	13	19	84	47	61	30
Depreciation Expense	26	26	23	18	16	15	16	15	13	13
Amortization Expense	23	26	36	67	64	51	57	37	28	29
Non-Cash Adjustments To Reconcile Net Income	62	64	57	46	51	44	50	45	38	41
Changes in Operating Assets and Liabilities, net	67	-112	-66	17	-25	14	-33	46	-11	-6.55
Net Cash From Investing Activities	113	470	241	-477	-358	-103	-197	-374	-50	-49
Net Cash From Continuing Investing Activities	113	470	241	-477	-358	-103	-197	-374	-50	-49
Purchase of Property, Plant & Equipment	-12	-23	-27	-30	-19	-23	-36	-17	-20	-18
Purchase of Investments	-74	-103	-607	-1,542	-520	-425	-396	-636	-185	-107
Divestitures	12	0.00	0.00	-	-	-	-	-	-	-
Sale and/or Maturity of Investments	186	596	874	1,095	497	345	474	294	162	172
Net Cash From Financing Activities	-45	-712	-887	-1,299	201	-30	-49	313	-52	-84
Net Cash From Continuing Financing Activities	-45	-712	-887	-1,299	201	-30	-49	313	-52	-84
Repayment of Debt	-45	-571	-0.02	-141	-625	-1.13	0.00	-83	-5.00	-95
Repurchase of Common Equity	-0.02	-217	-883	-1,150	-16	-27	-39	0.00	-41	-71
Issuance of Debt	0.00	80	0.00	0.00	845	0.00	0.00	400	0.00	81
Issuance of Common Equity	16	15	12	14	15	14	13	12	13	17
Other Financing Activities, net	-16	-18	-15	-22	-18	-16	-23	-16	-20	-16
Other Net Changes in Cash	0.00	0.00	-69	2,556	142	140	-	-	-	-
Cash Interest Paid	0.99	4.47	4.43	5.01	8.66	6.37	6.23	3.86	2.22	2.47
Cash Income Taxes Paid	19	32	132	266	7.22	10	21	8.93	11	2.16

This table details how cash moves in and out of Silicon Laboratories' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Net Change in Cash & Equivalents	-21	62	49	-36	68	-75	-482	216	17	-22
Net Cash From Operating Activities	10	32	16	-72	19	-33	-2.22	-13	14	44
Net Cash From Continuing Operating Activities	10	32	16	-72	19	-33	-2.22	-13	14	44
Net Income / (Loss) Continuing Operations	-24	-29	-82	-57	-70	10	11	14	25	21
Consolidated Net Income / (Loss)	-24	-29	-82	-57	-70	10	11	14	25	21
Depreciation Expense	6.25	6.15	6.52	6.63	6.72	6.55	6.21	6.24	6.01	5.95
Amortization Expense	5.44	5.44	6.08	6.08	6.21	6.26	6.83	7.03	7.25	8.63
Non-Cash Adjustments To Reconcile Net Income	16	16	16	14	26	5.85	15	18	17	14
Changes in Operating Assets and Liabilities, net	6.12	33	70	-42	49	-62	-41	-58	-42	-5.67
Net Cash From Investing Activities	-38	30	40	81	43	10	162	254	200	69
Net Cash From Continuing Investing Activities	-38	30	40	81	43	10	162	254	200	69
Purchase of Property, Plant & Equipment	-3.96	-2.21	-3.53	-2.05	-3.87	-5.25	-6.02	-7.66	-6.47	-7.74
Purchase of Investments	-45	-11	-7.91	-9.79	-12	-10	-15	-66	-28	-25
Sale and/or Maturity of Investments	11	43	51	81	59	26	183	328	234	102
Net Cash From Financing Activities	6.58	0.42	-6.40	-46	5.65	-52	-641	-25	-197	-103
Net Cash From Continuing Financing Activities	6.58	0.42	-6.40	-46	5.65	-52	-641	-25	-197	-103
Repurchase of Common Equity	-0.02	-	-	0.00	-	-16	-183	-18	-202	-103
Issuance of Common Equity	6.95	1.29	7.77	0.34	6.60	0.23	7.79	0.00	5.41	0.00
Other Financing Activities, net	-0.36	-0.87	-14	-1.05	-0.95	-0.93	-9.38	-6.93	-0.66	-0.77

This table presents Silicon Laboratories' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/28/2024	12/30/2023	12/31/2022	1/1/2022	1/2/2021	12/28/2019	12/29/2018	12/30/2017	12/31/2016	1/2/2016
Total Assets	1,223	1,443	2,169	2,958	1,993	1,675	1,624	1,535	1,082	1,011
Total Current Assets	602	738	1,461	2,239	976	944	827	948	491	423
Cash & Equivalents	282	228	500	1,075	203	227	197	269	141	114
Short-Term Investments	101	212	692	965	522	499	417	495	154	129
Accounts Receivable	54	29	71	98	95	76	73	71	74	74
Inventories, net	106	194	100	49	48	73	75	73	60	54
Prepaid Expenses	60	75	98	52	87	69	65	39	62	53
Plant, Property, & Equipment, net	132	146	152	147	136	136	139	128	130	131
Total Noncurrent Assets	489	559	556	573	882	595	659	460	461	457
Long-Term Investments	76	123	95	78	77	-	-	-	-	7.13
Goodwill	376	376	376	376	376	398	397	288	276	273
Intangible Assets	36	60	85	119	163	134	171	83	104	121
Total Liabilities & Shareholders' Equity	1,223	1,443	2,169	2,958	1,993	1,675	1,624	1,535	1,082	1,011
Total Liabilities	143	234	764	746	794	560	557	582	255	250
Total Current Liabilities	98	164	186	669	284	138	145	162	140	142
Short-Term Debt	0.00	45	0.00	451	134	0.00	-	-	-	10
Accounts Payable	42	57	90	47	55	39	41	39	40	42
Current Deferred Revenue	3.07	2.12	6.78	14	13	19	22	50	46	35
Other Current Liabilities	52	59	89	157	82	80	81	73	55	-
Total Noncurrent Liabilities	45	71	579	77	509	422	412	420	115	108
Other Noncurrent Operating Liabilities	45	71	49	77	80	-	-	-	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,080	1,209	1,405	2,212	1,200	1,115	1,067	953	827	761
Total Preferred & Common Equity	1,080	1,209	1,405	2,212	1,200	1,115	1,067	953	827	761
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,080	1,209	1,405	2,212	1,200	1,115	1,067	953	827	761
Common Stock	78	17	0.00	0.00	204	134	108	103	24	14
Retained Earnings	1,002	1,193	1,416	2,215	994	981	961	851	802	748
Accumulated Other Comprehensive Income / (Loss)	0.07	-1.03	-11	-2.42	1.81	0.65	-1.57	-1.16	0.49	-0.51

This table presents Silicon Laboratories' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/28/2024	6/29/2024	3/30/2024	9/30/2023	7/1/2023	4/1/2023	10/1/2022
Total Assets	1,249	1,250	1,344	1,475	1,519	2,161	2,336
Total Current Assets	614	600	646	774	821	1,461	1,626
Cash & Equivalents	303	241	191	160	235	716	483
Short-Term Investments	67	98	141	257	271	436	893
Accounts Receivable	49	41	33	102	98	88	77
Inventories, net	139	166	198	168	146	133	88
Prepaid Expenses	56	54	83	87	71	88	84
Plant, Property, & Equipment, net	135	139	142	151	152	152	152
Total Noncurrent Assets	500	511	556	551	545	549	559
Long-Term Investments	81	87	126	109	97	94	91
Goodwill	376	376	376	376	376	376	376
Intangible Assets	42	47	53	66	72	78	92
Total Liabilities & Shareholders' Equity	1,249	1,250	1,344	1,475	1,519	2,161	2,336
Total Liabilities	168	157	179	215	260	742	785
Total Current Liabilities	118	100	111	165	219	693	206
Short-Term Debt	0.00	0.00	0.00	45	80	530	0.00
Accounts Payable	45	39	45	48	55	71	82
Current Deferred Revenue	8.48	3.32	3.92	10	11	11	12
Other Current Liabilities	65	57	63	62	72	81	112
Total Noncurrent Liabilities	50	57	67	50	41	49	579
Other Noncurrent Operating Liabilities	50	57	67	50	41	49	50
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,081	1,093	1,166	1,260	1,259	1,419	1,552
Total Preferred & Common Equity	1,081	1,093	1,166	1,260	1,259	1,419	1,552
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,081	1,093	1,166	1,260	1,259	1,419	1,552
Common Stock	56	39	30	0.00	0.00	0.00	0.00
Retained Earnings	1,026	1,054	1,136	1,263	1,263	1,426	1,568
Accumulated Other Comprehensive Income / (Loss)	0.27	-0.25	-0.48	-2.60	-4.09	-6.46	-16

This table displays calculated financial ratios and metrics derived from Silicon Laboratories' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/28/2024	12/30/2023	12/31/2022	1/1/2022	1/2/2021	12/28/2019	12/29/2018	12/30/2017	12/31/2016	1/2/2016
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-25.30%	-23.62%	42.07%	41.09%	7.84%	-45.43%	12.93%	10.21%	8.19%	3.89%
EBITDA Growth	-519.21%	-84.32%	238.87%	295.70%	-20.64%	-114.06%	15.30%	27.91%	45.11%	-9.54%
EBIT Growth	-585.15%	-120.25%	463.18%	69.34%	-20.81%	-204.03%	0.28%	28.21%	105.61%	-37.03%
NOPAT Growth	-585.15%	-120.37%	461.07%	69.34%	-20.81%	-162.86%	89.69%	-17.66%	100.53%	-20.95%
Net Income Growth	-453.40%	-137.76%	-95.68%	16,797.29%	-34.95%	-76.95%	77.51%	-23.42%	107.85%	-22.19%
EPS Growth	-444.04%	-142.91%	-94.68%	16,964.29%	-34.88%	-77.37%	74.31%	-24.83%	110.14%	-20.69%
Operating Cash Flow Growth	54.17%	-121.48%	54.91%	1,131.77%	-139.86%	-87.22%	-8.43%	47.02%	22.25%	-23.28%
Free Cash Flow Firm Growth	21.98%	-218.11%	-117.59%	79.93%	891.99%	95.23%	-275.09%	100.23%	188.71%	-152.61%
Invested Capital Growth	-9.97%	6.68%	18.67%	-19.29%	-16.61%	-6.30%	42.21%	-5.93%	2.87%	15.07%
Revenue Q/Q Growth	15.72%	-17.89%	4.99%	28.46%	60.86%	-43.17%	1.70%	2.45%	3.34%	-0.29%
EBITDA Q/Q Growth	27.00%	-77.76%	8.25%	1,250.99%	76.02%	-116.76%	-2.09%	8.14%	15.24%	-4.28%
EBIT Q/Q Growth	21.19%	-133.07%	21.91%	63.97%	41.65%	-243.37%	-8.61%	8.02%	29.98%	-15.89%
NOPAT Q/Q Growth	21.19%	-132.60%	37.55%	63.97%	41.65%	-307.78%	37.43%	-32.80%	28.89%	-12.66%
Net Income Q/Q Growth	19.40%	-156.93%	45.21%	-0.57%	-5.77%	-21.99%	31.44%	-34.64%	30.72%	-12.86%
EPS Q/Q Growth	19.43%	-159.89%	22.71%	0.19%	-9.68%	-21.82%	31.94%	-34.73%	29.46%	-12.66%
Operating Cash Flow Q/Q Growth	-152.82%	13.36%	-17.08%	380.77%	90.42%	-86.42%	-10.21%	15.80%	3.42%	-10.08%
Free Cash Flow Firm Q/Q Growth	-2,382.90%	47.29%	89.87%	-83.21%	115.38%	-110.10%	16.59%	7.58%	-13.41%	-50.44%
Invested Capital Q/Q Growth	-1.27%	-11.31%	5.64%	49.10%	-36.79%	0.12%	1.25%	2.57%	7.84%	4.29%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	53.42%	58.88%	62.74%	59.01%	57.71%	59.14%	60.05%	59.07%	60.42%	59.05%
EBITDA Margin	-20.00%	3.56%	17.37%	7.28%	-5.25%	-4.69%	18.21%	17.84%	15.37%	11.46%
Operating Margin	-28.32%	-3.09%	11.65%	-4.56%	-20.96%	-18.71%	9.81%	11.05%	9.50%	5.00%
EBIT Margin	-28.32%	-3.09%	11.65%	-4.56%	-20.96%	-18.71%	9.81%	11.05%	9.50%	5.00%
Profit (Net Income) Margin	-32.69%	-4.41%	8.93%	293.73%	2.45%	4.07%	9.63%	6.12%	8.81%	4.59%
Tax Burden Percent	123.38%	327.38%	72.28%	-3,639.71%	-9.48%	-20.07%	115.84%	61.24%	95.35%	97.76%
Interest Burden Percent	93.55%	43.65%	106.03%	177.16%	123.45%	108.31%	84.69%	90.50%	97.31%	93.89%
Effective Tax Rate	0.00%	0.00%	30.41%	0.00%	0.00%	0.00%	-15.84%	38.76%	4.65%	2.24%
Return on Invested Capital (ROIC)	-17.64%	-2.53%	13.90%	-3.76%	-10.08%	-7.40%	13.39%	8.29%	9.90%	5.36%
ROIC Less NNEP Spread (ROIC-NNEP)	-2.23%	0.24%	13.21%	-199.25%	-31.23%	-39.57%	18.93%	10.17%	10.99%	6.48%
Return on Net Nonoperating Assets (RNNOA)	0.95%	-0.12%	-8.85%	127.87%	11.16%	9.17%	-5.11%	-3.00%	-2.16%	-1.47%
Return on Equity (ROE)	-16.69%	-2.64%	5.05%	124.11%	1.08%	1.77%	8.28%	5.29%	7.74%	3.90%
Cash Return on Invested Capital (CROIC)	-7.15%	-8.99%	-3.17%	17.59%	8.03%	-0.90%	-21.47%	14.39%	7.07%	-8.66%
Operating Return on Assets (OROA)	-12.42%	-1.34%	4.65%	-1.33%	-5.84%	-5.37%	5.39%	6.49%	6.33%	3.14%
Return on Assets (ROA)	-14.33%	-1.91%	3.57%	85.52%	0.68%	1.17%	5.29%	3.60%	5.88%	2.88%
Return on Common Equity (ROCE)	-16.69%	-2.64%	5.05%	124.11%	1.08%	1.77%	8.28%	5.29%	7.74%	3.90%
Return on Equity Simple (ROE_SIMPLE)	-17.69%	-2.86%	6.51%	95.70%	1.04%	1.73%	7.83%	4.94%	7.44%	3.89%
Net Operating Profit after Tax (NOPAT)	-116	-17	83	-23	-75	-62	99	52	63	32
NOPAT Margin	-19.82%	-2.16%	8.10%	-3.19%	-14.67%	-13.10%	11.37%	6.77%	9.06%	4.89%
Net Nonoperating Expense Percent (NNEP)	-15.41%	-2.76%	0.69%	195.49%	21.15%	32.17%	-5.54%	-1.89%	-1.09%	-1.12%
Return On Investment Capital (ROIC_SIMPLE)	-10.73%	-1.35%	4.29%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	46.58%	41.12%	37.26%	40.99%	42.29%	40.86%	39.95%	40.93%	39.58%	40.95%
SG&A Expenses to Revenue	24.89%	18.79%	18.65%	25.67%	32.64%	34.44%	22.79%	20.77%	22.29%	24.89%
R&D to Revenue	56.85%	43.18%	32.45%	37.90%	46.03%	43.41%	27.45%	27.25%	28.63%	29.16%
Operating Expenses to Revenue	81.74%	61.97%	51.10%	63.57%	78.67%	77.85%	50.24%	48.02%	50.92%	54.05%
Earnings before Interest and Taxes (EBIT)	-165	-24	119	-33	-107	-89	85	85	66	32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-117	28	178	52	-27	-22	158	137	107	74
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.84	3.48	3.21	3.75	4.65	4.53	3.17	3.94	3.28	2.65
Price to Tangible Book Value (P/TBV)	6.22	5.44	4.78	4.83	8.46	8.68	6.79	6.46	6.07	5.50
Price to Revenue (P/Rev)	7.10	5.37	4.41	11.51	10.92	10.67	3.90	4.89	3.89	3.13
Price to Earnings (P/E)	0.00	0.00	49.40	3.92	445.37	262.33	40.52	79.81	44.13	68.21
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	2.02%	25.52%	0.22%	0.38%	2.47%	1.25%	2.27%	1.47%
Enterprise Value to Invested Capital (EV/IC)	5.93	5.33	5.80	12.14	7.90	5.86	3.68	5.61	3.92	3.00
Enterprise Value to Revenue (EV/Rev)	6.31	4.71	3.67	9.20	10.46	10.03	3.67	4.44	3.63	2.92
Enterprise Value to EBITDA (EV/EBITDA)	0.00	132.17	21.13	126.30	0.00	0.00	20.15	24.90	23.63	25.53
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	31.51	0.00	0.00	0.00	37.39	40.18	38.23	58.51
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	45.28	0.00	0.00	0.00	32.27	65.61	40.10	59.85
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	26.60	72.69	0.00	214.19	18.36	18.02	19.66	17.89
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	61.66	89.43	0.00	0.00	37.78	56.13	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.04	0.38	0.20	0.47	0.38	0.39	0.44	0.14	0.16
Long-Term Debt to Equity	0.00	0.00	0.38	0.00	0.36	0.38	0.39	0.44	0.14	0.14
Financial Leverage	-0.43	-0.49	-0.67	-0.64	-0.36	-0.23	-0.27	-0.29	-0.20	-0.23
Leverage Ratio	1.16	1.38	1.42	1.45	1.58	1.51	1.56	1.47	1.32	1.35
Compound Leverage Factor	1.09	0.60	1.50	2.57	1.96	1.64	1.32	1.33	1.28	1.27
Debt to Total Capital	0.00%	3.59%	27.37%	16.92%	31.95%	27.46%	27.86%	30.58%	12.23%	13.43%
Short-Term Debt to Total Capital	0.00%	3.59%	0.00%	16.92%	7.63%	0.00%	0.00%	0.00%	0.00%	1.14%
Long-Term Debt to Total Capital	0.00%	0.00%	27.37%	0.00%	24.33%	27.46%	27.86%	30.58%	12.23%	12.29%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	96.41%	72.63%	83.08%	68.05%	72.54%	72.14%	69.42%	87.77%	86.57%
Debt to EBITDA	0.00	1.61	2.98	8.59	-21.01	-18.99	2.61	3.06	1.07	1.60
Net Debt to EBITDA	0.00	-18.56	-4.26	-31.75	8.87	13.67	-1.28	-2.51	-1.68	-1.79
Long-Term Debt to EBITDA	0.00	0.00	2.98	0.00	-15.99	-18.99	2.61	3.06	1.07	1.46
Debt to NOPAT	0.00	-2.66	6.38	-19.60	-7.52	-6.80	4.18	8.07	1.82	3.75
Net Debt to NOPAT	0.00	30.61	-9.12	72.50	3.17	4.90	-2.04	-6.62	-2.85	-4.19
Long-Term Debt to NOPAT	0.00	0.00	6.38	0.00	-5.72	-6.80	4.18	8.07	1.82	3.43
Altman Z-Score	19.11	12.88	5.82	8.57	5.41	6.92	5.69	5.95	8.66	6.95
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	6.15	4.51	7.87	3.35	3.43	6.85	5.71	5.84	3.51	2.97
Quick Ratio	4.46	2.86	6.80	3.20	2.88	5.82	4.74	5.15	2.64	2.22
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-47	-60	-19	108	60	-7.54	-158	90	45	-51
Operating Cash Flow to CapEx	-118.40%	-133.09%	532.61%	306.70%	-45.80%	95.48%	488.51%	1,101.10%	653.44%	596.86%
Free Cash Flow to Firm to Interest Expense	-35.83	-10.83	-2.81	3.46	1.75	-0.37	-8.04	6.40	17.45	-17.99
Operating Cash Flow to Interest Expense	-10.62	-5.46	21.01	2.94	-0.26	1.10	8.81	13.41	49.83	37.29
Operating Cash Flow Less CapEx to Interest Expense	-19.59	-9.57	17.07	1.98	-0.82	-0.05	7.01	12.20	42.20	31.04
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.44	0.43	0.40	0.29	0.28	0.29	0.55	0.59	0.67	0.63
Accounts Receivable Turnover	13.95	15.53	12.07	7.45	5.98	6.37	12.01	10.55	9.43	8.96
Inventory Turnover	1.82	2.18	5.10	6.08	3.57	2.62	4.68	4.74	4.87	4.96
Fixed Asset Turnover	4.20	5.25	6.86	5.11	3.76	3.45	6.51	5.98	5.35	4.89
Accounts Payable Turnover	5.45	4.37	5.56	5.78	4.61	4.84	8.67	8.02	6.76	6.52
Days Sales Outstanding (DSO)	26.16	23.50	30.25	48.98	61.01	57.33	30.39	34.60	38.72	40.75
Days Inventory Outstanding (DIO)	201.10	167.20	71.62	60.02	102.13	139.56	77.92	76.97	75.00	73.62
Days Payable Outstanding (DPO)	67.01	83.60	65.62	63.17	79.26	75.49	42.10	45.49	54.00	56.02
Cash Conversion Cycle (CCC)	160.25	107.10	36.25	45.83	83.87	121.40	66.21	66.08	59.71	58.35
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	622	691	648	546	676	811	866	609	647	629
Invested Capital Turnover	0.89	1.17	1.72	1.18	0.69	0.57	1.18	1.22	1.09	1.10
Increase / (Decrease) in Invested Capital	-69	43	102	-130	-135	-55	257	-38	18	82
Enterprise Value (EV)	3,688	3,686	3,758	6,629	5,343	4,750	3,186	3,414	2,534	1,886
Market Capitalization	4,146	4,203	4,515	8,295	5,581	5,054	3,387	3,759	2,714	2,018
Book Value per Share	$33.28	$38.03	$42.21	$55.05	$27.38	$25.71	$24.74	$22.39	$19.81	$18.31
Tangible Book Value per Share	$20.56	$24.32	$28.35	$42.73	$15.06	$13.43	$11.57	$13.66	$10.71	$8.83
Total Capital	1,080	1,254	1,935	2,663	1,763	1,537	1,480	1,373	942	879
Total Debt	0.00	45	530	451	563	422	412	420	115	118
Total Long-Term Debt	0.00	0.00	530	0.00	429	422	412	420	115	108
Net Debt	-458	-518	-757	-1,666	-238	-304	-202	-344	-180	-132
Capital Expenditures (CapEx)	12	23	27	30	19	23	36	17	20	18
Debt-free, Cash-free Net Working Capital (DFCFNWC)	122	180	84	-19	101	80	68	21	56	48
Debt-free Net Working Capital (DFNWC)	504	619	1,276	2,020	826	806	682	785	351	291
Net Working Capital (NWC)	504	574	1,276	1,570	691	806	682	785	351	281
Net Nonoperating Expense (NNE)	75	18	-8.41	-2,140	-87	-81	15	4.94	1.70	1.93
Net Nonoperating Obligations (NNO)	-458	-518	-757	-1,666	-523	-304	-202	-344	-180	-132
Total Depreciation and Amortization (D&A)	49	52	59	85	80	66	73	52	41	42
Debt-free, Cash-free Net Working Capital to Revenue	20.87%	23.03%	8.17%	-2.62%	19.79%	16.92%	7.83%	2.77%	8.04%	7.42%
Debt-free Net Working Capital to Revenue	86.27%	79.18%	124.56%	280.27%	161.63%	170.15%	78.52%	102.14%	50.34%	45.10%
Net Working Capital to Revenue	86.27%	73.42%	124.56%	217.76%	135.31%	170.15%	78.52%	102.14%	50.34%	43.55%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($5.93)	($1.09)	$2.61	$49.44	$0.29	$0.44	$1.94	$1.11	$1.47	$0.70
Adjusted Weighted Average Basic Shares Outstanding	32.19M	31.80M	35.09M	42.83M	43.78M	43.35M	43.16M	42.45M	41.71M	42.31M
Adjusted Diluted Earnings per Share	($5.93)	($1.09)	$2.54	$47.78	$0.28	$0.43	$1.90	$1.09	$1.45	$0.69
Adjusted Weighted Average Diluted Shares Outstanding	32.19M	31.80M	36.04M	44.32M	44.37M	44.29M	44.04M	43.33M	42.38M	42.95M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.46M	31.90M	31.90M	38.20M	43.93M	43.50M	43.09M	42.71M	41.89M	41.55M
Normalized Net Operating Profit after Tax (NOPAT)	-116	-17	83	-23	-75	-62	60	52	63	32
Normalized NOPAT Margin	-19.82%	-2.16%	8.10%	-3.19%	-14.67%	-13.10%	6.87%	6.77%	9.06%	4.89%
Pre Tax Income Margin	-26.49%	-1.35%	12.35%	-8.07%	-25.88%	-20.26%	8.31%	10.00%	9.25%	4.69%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-126.33	-4.35	17.74	-1.06	-3.14	-4.38	4.33	6.01	25.62	11.40
NOPAT to Interest Expense	-88.43	-3.04	12.35	-0.74	-2.20	-3.07	5.01	3.68	24.43	11.14
EBIT Less CapEx to Interest Expense	-135.30	-8.45	13.79	-2.02	-3.70	-5.53	2.52	4.80	17.99	5.15
NOPAT Less CapEx to Interest Expense	-97.40	-7.15	8.40	-1.70	-2.76	-4.21	3.21	2.46	16.80	4.90
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.01%	-629.09%	966.53%	54.31%	129.97%	138.68%	46.99%	0.00%	65.93%	241.49%

This table displays calculated financial ratios and metrics derived from Silicon Laboratories' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	91.43%	-18.34%	-40.63%	-56.90%	-66.25%	-24.48%	-6.95%	5.55%	23.31%	45.98%
EBITDA Growth	71.85%	-172.41%	-217.28%	-241.35%	-261.18%	-44.15%	-34.52%	-33.77%	56.97%	273.68%
EBIT Growth	60.84%	-343.17%	-379.73%	-402.12%	-403.68%	-59.58%	-45.29%	-41.72%	812.28%	425.85%
NOPAT Growth	60.84%	-325.63%	-515.18%	-420.79%	-326.03%	-46.95%	-61.40%	-40.89%	1,125.67%	367.57%
Net Income Growth	65.86%	-375.45%	-849.88%	-504.71%	-375.17%	-50.72%	-50.50%	-39.03%	918.62%	-98.99%
EPS Growth	66.51%	-375.00%	-875.76%	-531.71%	-382.89%	-46.67%	-45.00%	-29.31%	162.07%	-98.72%
Operating Cash Flow Growth	-45.36%	194.73%	826.76%	-440.66%	33.76%	-175.80%	-20.98%	-115.59%	-67.74%	3.62%
Free Cash Flow Firm Growth	151.74%	181.80%	122.68%	74.70%	-19.13%	31.75%	-177.01%	-126.93%	-159.90%	-132.94%
Invested Capital Growth	-9.97%	-19.13%	-9.36%	0.45%	6.68%	27.07%	28.57%	36.74%	18.67%	67.48%
Revenue Q/Q Growth	-0.09%	14.47%	36.66%	22.49%	-57.38%	-16.79%	-0.78%	-4.10%	-4.63%	2.53%
EBITDA Q/Q Growth	6.52%	48.84%	23.69%	22.87%	-340.49%	-17.14%	-8.03%	-12.05%	-16.67%	-2.86%
EBIT Q/Q Growth	3.64%	38.14%	18.79%	19.12%	-698.44%	-28.83%	-12.29%	-18.70%	-20.34%	-3.68%
NOPAT Q/Q Growth	3.64%	38.14%	18.79%	19.12%	-655.27%	13.84%	-37.25%	-43.01%	30.33%	-17.17%
Net Income Q/Q Growth	16.42%	65.31%	-45.34%	19.00%	-774.40%	-5.55%	-21.56%	-44.93%	20.77%	-5.13%
EPS Q/Q Growth	18.18%	65.63%	-44.63%	17.67%	-771.88%	-3.03%	-19.51%	-46.05%	26.67%	0.00%
Operating Cash Flow Q/Q Growth	-67.97%	96.03%	122.47%	-487.33%	155.52%	-1,403.83%	83.28%	-195.83%	-68.53%	2,500.11%
Free Cash Flow Firm Q/Q Growth	-61.90%	263.74%	179.11%	52.81%	39.77%	-0.85%	11.75%	-122.21%	65.49%	-213.80%
Invested Capital Q/Q Growth	-1.27%	-5.52%	-5.62%	2.27%	-11.31%	5.89%	4.59%	8.61%	5.64%	7.14%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	54.27%	54.28%	52.68%	51.77%	50.58%	58.41%	58.72%	62.35%	61.13%	61.37%
EBITDA Margin	-10.19%	-10.89%	-24.37%	-43.64%	-69.30%	12.28%	12.33%	13.31%	14.51%	16.61%
Operating Margin	-17.22%	-17.85%	-33.03%	-55.59%	-84.19%	6.00%	7.01%	7.93%	9.36%	11.20%
EBIT Margin	-17.22%	-17.85%	-33.03%	-55.59%	-84.19%	6.00%	7.01%	7.93%	9.36%	11.20%
Profit (Net Income) Margin	-14.33%	-17.13%	-56.52%	-53.14%	-80.36%	5.08%	4.47%	5.66%	9.86%	7.78%
Tax Burden Percent	91.95%	107.57%	180.59%	99.32%	99.07%	75.01%	46.92%	61.39%	95.61%	62.93%
Interest Burden Percent	90.51%	89.20%	94.74%	96.24%	96.35%	112.92%	136.02%	116.25%	110.18%	110.41%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	24.56%	52.84%	34.07%	5.95%	42.52%
Return on Invested Capital (ROIC)	-10.73%	-8.96%	-17.88%	-35.41%	-68.85%	6.19%	5.15%	8.90%	15.10%	12.82%
ROIC Less NNEP Spread (ROIC-NNEP)	-9.95%	-7.30%	-7.65%	-32.84%	-65.93%	6.03%	4.78%	8.81%	14.87%	12.60%
Return on Net Nonoperating Assets (RNNOA)	4.24%	2.91%	3.08%	14.92%	32.15%	-3.04%	-2.60%	-5.68%	-9.96%	-9.66%
Return on Equity (ROE)	-6.49%	-6.05%	-14.79%	-20.49%	-36.70%	3.15%	2.55%	3.23%	5.13%	3.16%
Cash Return on Invested Capital (CROIC)	-7.15%	0.29%	-6.95%	-10.66%	-8.99%	-16.39%	-15.79%	-18.91%	-3.17%	-38.13%
Operating Return on Assets (OROA)	-7.55%	-6.62%	-12.94%	-20.36%	-36.46%	3.00%	3.63%	3.29%	3.74%	3.66%
Return on Assets (ROA)	-6.28%	-6.35%	-22.14%	-19.46%	-34.80%	2.54%	2.32%	2.35%	3.94%	2.54%
Return on Common Equity (ROCE)	-6.49%	-6.05%	-14.79%	-20.49%	-36.70%	3.15%	2.55%	3.23%	5.13%	3.16%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-21.91%	-18.13%	-9.01%	0.00%	4.81%	5.66%	5.81%	0.00%	4.06%
Net Operating Profit after Tax (NOPAT)	-20	-21	-34	-41	-51	9.22	8.10	13	23	17
NOPAT Margin	-12.05%	-12.50%	-23.12%	-38.91%	-58.93%	4.52%	3.31%	5.23%	8.80%	6.44%
Net Nonoperating Expense Percent (NNEP)	-0.78%	-1.65%	-10.23%	-2.58%	-2.92%	0.16%	0.37%	0.10%	0.22%	0.23%
Return On Investment Capital (ROIC_SIMPLE)	-1.86%	-	-	-	-4.08%	-	-	-	1.17%	-
Cost of Revenue to Revenue	45.73%	45.72%	47.32%	48.23%	49.42%	41.59%	41.28%	37.65%	38.87%	38.63%
SG&A Expenses to Revenue	21.90%	22.11%	26.62%	31.54%	38.73%	13.63%	16.62%	18.19%	18.10%	18.80%
R&D to Revenue	49.59%	50.02%	59.10%	75.82%	96.04%	38.79%	35.08%	36.22%	33.67%	31.36%
Operating Expenses to Revenue	71.49%	72.13%	85.72%	107.36%	134.77%	52.42%	51.71%	54.41%	51.77%	50.17%
Earnings before Interest and Taxes (EBIT)	-29	-30	-48	-59	-73	12	17	20	24	30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-17	-18	-35	-46	-60	25	30	33	37	45
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.84	3.48	3.23	3.92	3.48	2.93	4.01	3.93	3.21	2.72
Price to Tangible Book Value (P/TBV)	6.22	5.67	5.28	6.21	5.44	4.52	6.23	5.79	4.78	3.90
Price to Revenue (P/Rev)	7.10	7.45	6.51	7.12	5.37	3.88	4.95	5.39	4.41	4.33
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	60.90	70.81	67.73	49.40	67.12
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	1.64%	1.41%	1.48%	2.02%	1.49%
Enterprise Value to Invested Capital (EV/IC)	5.93	5.25	4.66	5.81	5.33	4.12	6.15	6.92	5.80	5.36
Enterprise Value to Revenue (EV/Rev)	6.31	6.56	5.73	6.40	4.71	3.37	4.44	4.70	3.67	3.37
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	132.17	25.61	31.16	30.22	21.13	20.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	43.98	49.70	46.27	31.51	33.59
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	61.94	75.10	65.91	45.28	54.46
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	106.70	113.81	26.60	19.29
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	1,610.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.04	0.04	0.06	0.37	0.38	0.34
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.38	0.34
Financial Leverage	-0.43	-0.40	-0.40	-0.45	-0.49	-0.50	-0.54	-0.64	-0.67	-0.77
Leverage Ratio	1.16	1.16	1.18	1.36	1.38	1.36	1.38	1.46	1.42	1.42
Compound Leverage Factor	1.05	1.04	1.12	1.31	1.33	1.53	1.87	1.70	1.56	1.57
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	3.59%	3.45%	5.98%	27.19%	27.37%	25.43%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	3.59%	3.45%	5.98%	27.19%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	27.37%	25.43%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	96.41%	96.55%	94.02%	72.81%	72.63%	74.57%
Debt to EBITDA	0.00	0.00	0.00	0.00	1.61	0.36	0.55	3.29	2.98	3.22
Net Debt to EBITDA	0.00	0.00	0.00	0.00	-18.56	-3.83	-3.60	-4.44	-4.26	-5.71
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.98	3.22
Debt to NOPAT	0.00	0.00	0.00	0.00	-2.66	0.87	1.33	7.18	6.38	8.77
Net Debt to NOPAT	0.00	0.00	0.00	0.00	30.61	-9.27	-8.68	-9.69	-9.12	-15.55
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.38	8.77
Altman Z-Score	19.48	15.40	15.47	17.34	12.77	12.67	14.00	6.38	5.67	5.36
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	6.15	5.19	5.99	5.80	4.51	4.68	3.76	2.11	7.87	7.90
Quick Ratio	4.46	3.54	3.80	3.28	2.86	3.14	2.76	1.79	6.80	7.06
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	49	128	35	-45	-94	-157	-155	-176	-79	-230
Operating Cash Flow to CapEx	255.59%	1,432.38%	457.05%	-3,507.57%	478.50%	-635.78%	-36.88%	-173.44%	214.25%	569.39%
Free Cash Flow to Firm to Interest Expense	187.94	461.30	134.05	-87.56	-100.14	-115.36	-97.40	-106.37	-42.87	-150.44
Operating Cash Flow to Interest Expense	38.96	113.77	61.35	-141.06	19.66	-24.57	-1.39	-8.02	7.49	28.84
Operating Cash Flow Less CapEx to Interest Expense	23.72	105.82	47.92	-145.08	15.55	-28.43	-5.16	-12.64	4.00	23.78
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.44	0.37	0.39	0.37	0.43	0.50	0.52	0.41	0.40	0.33
Accounts Receivable Turnover	13.95	6.69	7.78	10.67	15.53	10.66	11.96	12.43	12.07	13.07
Inventory Turnover	1.82	1.56	1.59	1.69	2.18	2.96	3.63	4.20	5.10	4.91
Fixed Asset Turnover	4.20	3.53	3.72	4.36	5.25	6.30	6.75	6.91	6.86	6.61
Accounts Payable Turnover	5.45	5.16	5.25	4.83	4.37	5.84	5.29	5.84	5.56	5.19
Days Sales Outstanding (DSO)	26.16	54.58	46.93	34.21	23.50	34.25	30.52	29.38	30.25	27.93
Days Inventory Outstanding (DIO)	201.10	234.39	229.54	215.99	167.20	123.36	100.60	86.89	71.62	74.32
Days Payable Outstanding (DPO)	67.01	70.78	69.54	75.60	83.60	62.52	68.95	62.53	65.62	70.33
Cash Conversion Cycle (CCC)	160.25	218.18	206.93	174.60	107.10	95.09	62.17	53.74	36.25	31.91
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	622	630	667	707	691	779	736	704	648	613
Invested Capital Turnover	0.89	0.72	0.77	0.91	1.17	1.37	1.56	1.70	1.72	1.99
Increase / (Decrease) in Invested Capital	-69	-149	-69	3.17	43	166	164	189	102	247
Enterprise Value (EV)	3,688	3,312	3,106	4,109	3,686	3,212	4,524	4,869	3,758	3,286
Market Capitalization	4,146	3,763	3,532	4,567	4,203	3,693	5,047	5,585	4,515	4,225
Book Value per Share	$33.28	$33.49	$34.24	$36.53	$38.03	$39.54	$39.34	$44.50	$42.21	$45.34
Tangible Book Value per Share	$20.56	$20.54	$20.96	$23.06	$24.32	$25.66	$25.33	$30.24	$28.35	$31.66
Total Capital	1,080	1,081	1,093	1,166	1,254	1,305	1,339	1,950	1,935	2,081
Total Debt	0.00	0.00	0.00	0.00	45	45	80	530	530	529
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	530	529
Net Debt	-458	-451	-426	-459	-518	-481	-523	-716	-757	-938
Capital Expenditures (CapEx)	3.96	2.21	3.53	2.05	3.87	5.25	6.02	7.66	6.47	7.74
Debt-free, Cash-free Net Working Capital (DFCFNWC)	122	126	161	202	180	236	177	145	84	44
Debt-free Net Working Capital (DFNWC)	504	496	500	535	619	653	682	1,298	1,276	1,420
Net Working Capital (NWC)	504	496	500	535	574	608	602	767	1,276	1,420
Net Nonoperating Expense (NNE)	3.78	7.71	49	15	19	-1.13	-2.86	-1.06	-2.72	-3.63
Net Nonoperating Obligations (NNO)	-458	-451	-426	-459	-518	-481	-523	-716	-757	-938
Total Depreciation and Amortization (D&A)	12	12	13	13	13	13	13	13	13	15
Debt-free, Cash-free Net Working Capital to Revenue	20.87%	24.98%	29.64%	31.48%	23.03%	24.80%	17.33%	14.02%	8.17%	4.46%
Debt-free Net Working Capital to Revenue	86.27%	98.19%	92.18%	83.32%	79.18%	68.58%	66.98%	125.11%	124.56%	145.57%
Net Working Capital to Revenue	86.27%	98.19%	92.18%	83.32%	73.42%	63.86%	59.13%	74.00%	124.56%	145.57%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.72)	($0.88)	($2.56)	($1.77)	($2.21)	$0.33	$0.35	$0.44	$0.77	$0.62
Adjusted Weighted Average Basic Shares Outstanding	32.19M	32.31M	32.12M	31.91M	31.80M	31.80M	31.61M	31.96M	35.09M	34.08M
Adjusted Diluted Earnings per Share	($0.72)	($0.88)	($2.56)	($1.77)	($2.15)	$0.32	$0.33	$0.41	$0.76	$0.60
Adjusted Weighted Average Diluted Shares Outstanding	32.19M	32.31M	32.12M	31.91M	31.80M	32.08M	32.93M	33.75M	36.04M	34.78M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.46M	32.45M	32.29M	31.92M	31.90M	31.78M	31.86M	32.00M	31.90M	33.28M
Normalized Net Operating Profit after Tax (NOPAT)	-20	-21	-34	-41	-51	9.22	12	13	23	17
Normalized NOPAT Margin	-12.05%	-12.50%	-23.12%	-38.91%	-58.93%	4.52%	4.91%	5.23%	8.80%	6.44%
Pre Tax Income Margin	-15.58%	-15.93%	-31.30%	-53.50%	-81.11%	6.77%	9.54%	9.22%	10.31%	12.37%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-110.10	-106.86	-182.59	-116.18	-77.53	8.99	10.76	11.82	13.02	19.79
NOPAT to Interest Expense	-77.07	-74.80	-127.81	-81.32	-54.27	6.78	5.07	7.79	12.25	11.38
EBIT Less CapEx to Interest Expense	-125.35	-114.81	-196.01	-120.20	-81.64	5.13	6.98	7.20	9.52	14.73
NOPAT Less CapEx to Interest Expense	-92.32	-82.75	-141.23	-85.35	-58.38	2.92	1.30	3.17	8.75	6.31
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.01%	0.00%	-8.10%	-190.01%	-629.09%	690.83%	709.12%	901.33%	966.53%	1,816.51%

Frequently Asked Questions About Silicon Laboratories' Financials

When does Silicon Laboratories's financial year end?

According to the most recent income statement we have on file, Silicon Laboratories' fiscal year ends in December. Their fiscal year 2024 ended on December 28, 2024.

How has Silicon Laboratories' net income changed over the last 9 years?

Silicon Laboratories' net income appears to be on an upward trend, with a most recent value of -$191.01 million in 2024, falling from $29.59 million in 2015. The previous period was -$34.52 million in 2023. Find out what analysts predict for Silicon Laboratories in the coming months.

What is Silicon Laboratories's operating income?

Silicon Laboratories's total operating income in 2024 was -$165.49 million, based on the following breakdown:

Total Gross Profit: $312.19 million
Total Operating Expenses: $477.68 million

How has Silicon Laboratories revenue changed over the last 9 years?

Over the last 9 years, Silicon Laboratories' total revenue changed from $644.83 million in 2015 to $584.39 million in 2024, a change of -9.4%.

How much debt does Silicon Laboratories have?

Silicon Laboratories' total liabilities were at $142.65 million at the end of 2024, a 39.1% decrease from 2023, and a 43.0% decrease since 2015.

How much cash does Silicon Laboratories have?

In the past 9 years, Silicon Laboratories' cash and equivalents has ranged from $114.09 million in 2015 to $1.07 billion in 2021, and is currently $281.61 million as of their latest financial filing in 2024.

How has Silicon Laboratories' book value per share changed over the last 9 years?

Over the last 9 years, Silicon Laboratories' book value per share changed from 18.31 in 2015 to 33.28 in 2024, a change of 81.8%.

Related Companies

This page (NASDAQ:SLAB) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Silicon Laboratories (SLAB) Financials

Frequently Asked Questions About Silicon Laboratories' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Silicon Laboratories (SLAB) Financials

Annual Income Statements for Silicon Laboratories

Quarterly Income Statements for Silicon Laboratories

Annual Cash Flow Statements for Silicon Laboratories

Quarterly Cash Flow Statements for Silicon Laboratories

Annual Balance Sheets for Silicon Laboratories

Quarterly Balance Sheets for Silicon Laboratories

Annual Metrics And Ratios for Silicon Laboratories

Quarterly Metrics And Ratios for Silicon Laboratories

Frequently Asked Questions About Silicon Laboratories' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools